Global Basal Insulin (Long-Acting Insulin) Market Growth 2021-2026

  • receipt Report ID : 265070
  • calendar_today Published On: Apr, 2021
  • file_copy Pages: 134
  • list Pharmaceuticals and Healthcare

According to this latest study, the 2021 growth of Basal Insulin (Long-Acting Insulin) will have significant change from previous year. By the most conservative estimates of global Basal Insulin (Long-Acting Insulin) market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ xx million in 2020. Over the next five years the Basal Insulin (Long-Acting Insulin) market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2026.

This report presents a comprehensive overview, market shares, and growth opportunities of Basal Insulin (Long-Acting Insulin) market by product type, application, key manufacturers and key regions and countries.

Segmentation by type: breakdown data from 2016 to 2021, in Section 2.3; and forecast to 2026 in section 11.7.

Lantus

Levemir

Tresiba

Toujeo

Basaglar

Biosimilar Glargines

Segmentation by application: breakdown data from 2016 to 2021, in Section 2.4; and forecast to 2026 in section 11.8.

Type 1 Diabetes

Type 2 Diabetes

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.

Americas

United States

Canada

Mexico

Brazil

APAC

China

Japan

Korea

Southeast Asia

India

Australia

Europe

Germany

France

UK

Italy

Russia

Middle East & Africa

Egypt

South Africa

Israel

Turkey

GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in Chapter 3.

Novo Nordisk

Sanofi Aventis

Eli Lilly

Biocon

Julphar

Exir

Sedico

Wockhardt

Frequently Asked Questions

The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.

Market is segmented on the basis:

  • By Type
  • By Application
  • By Region
  • By Country
  • By Manufacturer

The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.

The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.

1 Scope of the Report

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Basal Insulin (Long-Acting Insulin) Consumption 2016-2026

2.1.2 Basal Insulin (Long-Acting Insulin) Consumption CAGR by Region

2.2 Basal Insulin (Long-Acting Insulin) Segment by Type

2.2.1 Lantus

2.2.2 Levemir

2.2.3 Tresiba

2.2.4 Toujeo

2.2.5 Basaglar

2.2.6 Biosimilar Glargines

2.3 Basal Insulin (Long-Acting Insulin) Sales by Type

2.3.1 Global Basal Insulin (Long-Acting Insulin) Sales Market Share by Type (2016-2021)

2.3.2 Global Basal Insulin (Long-Acting Insulin) Revenue and Market Share by Type (2016-2021)

2.3.3 Global Basal Insulin (Long-Acting Insulin) Sale Price by Type (2016-2021)

2.4 Basal Insulin (Long-Acting Insulin) Segment by Application

2.4.1 Type 1 Diabetes

2.4.2 Type 2 Diabetes

2.5 Basal Insulin (Long-Acting Insulin) Sales by Application

2.5.1 Global Basal Insulin (Long-Acting Insulin) Sale Market Share by Application (2016-2021)

2.5.2 Global Basal Insulin (Long-Acting Insulin) Revenue and Market Share by Application (2016-2021)

2.5.3 Global Basal Insulin (Long-Acting Insulin) Sale Price by Application (2016-2021)

3 Global Basal Insulin (Long-Acting Insulin) by Company

3.1 Global Basal Insulin (Long-Acting Insulin) Sales Market Share by Company

3.1.1 Global Basal Insulin (Long-Acting Insulin) Sales by Company (2019-2021)

3.1.2 Global Basal Insulin (Long-Acting Insulin) Sales Market Share by Company (2019-2021)

3.2 Global Basal Insulin (Long-Acting Insulin) Revenue Market Share by Company

3.2.1 Global Basal Insulin (Long-Acting Insulin) Revenue by Company (2019-2021)

3.2.2 Global Basal Insulin (Long-Acting Insulin) Revenue Market Share by Company (2019-2021)

3.3 Global Basal Insulin (Long-Acting Insulin) Sale Price by Company

3.4 Global Manufacturers Basal Insulin (Long-Acting Insulin) Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers Basal Insulin (Long-Acting Insulin) Product Location Distribution

3.4.2 Players Basal Insulin (Long-Acting Insulin) Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 Basal Insulin (Long-Acting Insulin) by Region

4.1 Global Basal Insulin (Long-Acting Insulin) by Region

4.1.1 Global Basal Insulin (Long-Acting Insulin) Sales by Region

4.1.2 Global Basal Insulin (Long-Acting Insulin) Revenue by Region

4.2 Americas Basal Insulin (Long-Acting Insulin) Sales Growth

4.3 APAC Basal Insulin (Long-Acting Insulin) Sales Growth

4.4 Europe Basal Insulin (Long-Acting Insulin) Sales Growth

4.5 Middle East & Africa Basal Insulin (Long-Acting Insulin) Sales Growth

5 Americas

5.1 Americas Basal Insulin (Long-Acting Insulin) Sales by Country

5.1.1 Americas Basal Insulin (Long-Acting Insulin) Sales by Country (2016-2021)

5.1.2 Americas Basal Insulin (Long-Acting Insulin) Revenue by Country (2016-2021)

5.2 Americas Basal Insulin (Long-Acting Insulin) Sales by Type

5.3 Americas Basal Insulin (Long-Acting Insulin) Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Basal Insulin (Long-Acting Insulin) Sales by Region

6.1.1 APAC Basal Insulin (Long-Acting Insulin) Sales by Region (2016-2021)

6.1.2 APAC Basal Insulin (Long-Acting Insulin) Revenue by Region (2016-2021)

6.2 APAC Basal Insulin (Long-Acting Insulin) Sales by Type

6.3 APAC Basal Insulin (Long-Acting Insulin) Sales by Application

6.4 China

6.5 Japan

6.6 Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

7 Europe

7.1 Europe Basal Insulin (Long-Acting Insulin) by Country

7.1.1 Europe Basal Insulin (Long-Acting Insulin) Sales by Country (2016-2021)

7.1.2 Europe Basal Insulin (Long-Acting Insulin) Revenue by Country (2016-2021)

7.2 Europe Basal Insulin (Long-Acting Insulin) Sales by Type

7.3 Europe Basal Insulin (Long-Acting Insulin) Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Basal Insulin (Long-Acting Insulin) by Country

8.1.1 Middle East & Africa Basal Insulin (Long-Acting Insulin) Sales by Country (2016-2021)

8.1.2 Middle East & Africa Basal Insulin (Long-Acting Insulin) Revenue by Country (2016-2021)

8.2 Middle East & Africa Basal Insulin (Long-Acting Insulin) Sales by Type

8.3 Middle East & Africa Basal Insulin (Long-Acting Insulin) Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Country

9 Market Drivers, Challenges and Trends

9.1 Market Drivers and Impact

9.1.1 Growing Demand from Key Regions

9.1.2 Growing Demand from Key Applications and Potential Industries

9.2 Market Challenges and Impact

9.3 Market Trends

10 Marketing, Distributors and Customer

10.1 Sales Channel

10.1.1 Direct Channels

10.1.2 Indirect Channels

10.2 Basal Insulin (Long-Acting Insulin) Distributors

10.3 Basal Insulin (Long-Acting Insulin) Customer

11 Global Basal Insulin (Long-Acting Insulin) Market Forecast

11.1 Global Basal Insulin (Long-Acting Insulin) Forecast by Region

11.1.1 Global Basal Insulin (Long-Acting Insulin) Forecast by Regions (2021-2026)

11.2.2 Global Basal Insulin (Long-Acting Insulin) Revenue Forecast by Regions (2021-2026)

11.2 Americas Forecast by Country

11.3 APAC Forecast by Region

11.4 Europe Forecast by Country

11.5 Middle East & Africa Forecast by Country

11.6 Global Basal Insulin (Long-Acting Insulin) Forecast by Type

11.7 Global Basal Insulin (Long-Acting Insulin) Forecast by Application

12 Key Players Analysis

12.1 Novo Nordisk

12.1.1 Novo Nordisk Company Information

12.1.2 Novo Nordisk Basal Insulin (Long-Acting Insulin) Product Offered

12.1.3 Novo Nordisk Basal Insulin (Long-Acting Insulin) Sales, Revenue, Price and Gross Margin (2019-2021)

12.1.4 Novo Nordisk Main Business Overview

12.1.5 Novo Nordisk Latest Developments

12.2 Sanofi Aventis

12.2.1 Sanofi Aventis Company Information

12.2.2 Sanofi Aventis Basal Insulin (Long-Acting Insulin) Product Offered

12.2.3 Sanofi Aventis Basal Insulin (Long-Acting Insulin) Sales, Revenue, Price and Gross Margin (2019-2021)

12.2.4 Sanofi Aventis Main Business Overview

12.2.5 Sanofi Aventis Latest Developments

12.3 Eli Lilly

12.3.1 Eli Lilly Company Information

12.3.2 Eli Lilly Basal Insulin (Long-Acting Insulin) Product Offered

12.3.3 Eli Lilly Basal Insulin (Long-Acting Insulin) Sales, Revenue, Price and Gross Margin (2019-2021)

12.3.4 Eli Lilly Main Business Overview

12.3.5 Eli Lilly Latest Developments

12.4 Biocon

12.4.1 Biocon Company Information

12.4.2 Biocon Basal Insulin (Long-Acting Insulin) Product Offered

12.4.3 Biocon Basal Insulin (Long-Acting Insulin) Sales, Revenue, Price and Gross Margin (2019-2021)

12.4.4 Biocon Main Business Overview

12.4.5 Biocon Latest Developments

12.5 Julphar

12.5.1 Julphar Company Information

12.5.2 Julphar Basal Insulin (Long-Acting Insulin) Product Offered

12.5.3 Julphar Basal Insulin (Long-Acting Insulin) Sales, Revenue, Price and Gross Margin (2019-2021)

12.5.4 Julphar Main Business Overview

12.5.5 Julphar Latest Developments

12.6 Exir

12.6.1 Exir Company Information

12.6.2 Exir Basal Insulin (Long-Acting Insulin) Product Offered

12.6.3 Exir Basal Insulin (Long-Acting Insulin) Sales, Revenue, Price and Gross Margin (2019-2021)

12.6.4 Exir Main Business Overview

12.6.5 Exir Latest Developments

12.7 Sedico

12.7.1 Sedico Company Information

12.7.2 Sedico Basal Insulin (Long-Acting Insulin) Product Offered

12.7.3 Sedico Basal Insulin (Long-Acting Insulin) Sales, Revenue, Price and Gross Margin (2019-2021)

12.7.4 Sedico Main Business Overview

12.7.5 Sedico Latest Developments

12.8 Wockhardt

12.8.1 Wockhardt Company Information

12.8.2 Wockhardt Basal Insulin (Long-Acting Insulin) Product Offered

12.8.3 Wockhardt Basal Insulin (Long-Acting Insulin) Sales, Revenue, Price and Gross Margin (2019-2021)

12.8.4 Wockhardt Main Business Overview

12.8.5 Wockhardt Latest Developments

13 Research Findings and Conclusion

List of Tables

Table 1. Basal Insulin (Long-Acting Insulin) Consumption CAGR by Region (2020-2026) & ($ Millions)

Table 2. Major Players of Lantus

Table 3. Major Players of Levemir

Table 4. Major Players of Tresiba

Table 5. Major Players of Toujeo

Table 6. Major Players of Basaglar

Table 7. Major Players of Biosimilar Glargines

Table 8. Global Basal Insulin (Long-Acting Insulin) Sales by Type (2016-2021) & (K Units)

Table 9. Global Basal Insulin (Long-Acting Insulin) Sales Market Share by Type (2016-2021)

Table 10. Global Basal Insulin (Long-Acting Insulin) Revenue by Type (2016-2021) & ($ million)

Table 11. Global Basal Insulin (Long-Acting Insulin) Revenue Market Share by Type (2016-2021)

Table 12. Global Basal Insulin (Long-Acting Insulin) Sale Price by Type (2016-2021)

Table 13. Global Basal Insulin (Long-Acting Insulin) Sales by Application (2016-2021) & (K Units)

Table 14. Global Basal Insulin (Long-Acting Insulin) Sales Market Share by Application (2016-2021)

Table 15. Global Basal Insulin (Long-Acting Insulin) Value by Application (2016-2021)

Table 16. Global Basal Insulin (Long-Acting Insulin) Revenue Market Share by Application (2016-2021)

Table 17. Global Basal Insulin (Long-Acting Insulin) Sale Price by Application (2016-2021)

Table 18. Global Basal Insulin (Long-Acting Insulin) Sales by Company (2019-2021) & (K Units)

Table 19. Global Basal Insulin (Long-Acting Insulin) Sales Market Share by Company (2019-2021)

Table 20. Global Basal Insulin (Long-Acting Insulin) Revenue by Company (2019-2021) ($ Millions)

Table 21. Global Basal Insulin (Long-Acting Insulin) Revenue Market Share by Company (2019-2021)

Table 22. Global Basal Insulin (Long-Acting Insulin) Sale Price by Company (2019-2021)

Table 23. Key Manufacturers Basal Insulin (Long-Acting Insulin) Producing Area Distribution and Sales Area

Table 24. Players Basal Insulin (Long-Acting Insulin) Products Offered

Table 25. Basal Insulin (Long-Acting Insulin) Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)

Table 26. New Products and Potential Entrants

Table 27. Mergers & Acquisitions, Expansion

Table 28. Global Basal Insulin (Long-Acting Insulin) Sales by Region (2016-2021) (K Units)

Table 29. Global Basal Insulin (Long-Acting Insulin) Sales Market Share by Region (2016-2021)

Table 30. Global Basal Insulin (Long-Acting Insulin) Revenue by Region (2016-2021) & ($ Millions)

Table 31. Global Basal Insulin (Long-Acting Insulin) Revenue Market Share by Region (2016-2021)

Table 32. Americas Basal Insulin (Long-Acting Insulin) Sales by Country (2016-2021) & (K Units)

Table 33. Americas Basal Insulin (Long-Acting Insulin) Sales Market Share by Country (2016-2021)

Table 34. Americas Basal Insulin (Long-Acting Insulin) Revenue by Country (2016-2021) & ($ Millions)

Table 35. Americas Basal Insulin (Long-Acting Insulin) Revenue Market Share by Country (2016-2021)

Table 36. Americas Basal Insulin (Long-Acting Insulin) Sales by Type (2016-2021) & (K Units)

Table 37. Americas Basal Insulin (Long-Acting Insulin) Sales Market Share by Type (2016-2021)

Table 38. Americas Basal Insulin (Long-Acting Insulin) Sales by Application (2016-2021) & (K Units)

Table 39. Americas Basal Insulin (Long-Acting Insulin) Sales Market Share by Application (2016-2021)

Table 40. APAC Basal Insulin (Long-Acting Insulin) Sales by Region (2016-2021) & (K Units)

Table 41. APAC Basal Insulin (Long-Acting Insulin) Sales Market Share by Region (2016-2021)

Table 42. APAC Basal Insulin (Long-Acting Insulin) Revenue by Region (2016-2021) & ($ Millions)

Table 43. APAC Basal Insulin (Long-Acting Insulin) Revenue Market Share by Region (2016-2021)

Table 44. APAC Basal Insulin (Long-Acting Insulin) Sales by Type (2016-2021) & (K Units)

Table 45. APAC Basal Insulin (Long-Acting Insulin) Sales Market Share by Type (2016-2021)

Table 46. APAC Basal Insulin (Long-Acting Insulin) Sales by Application (2016-2021) & (K Units)

Table 47. APAC Basal Insulin (Long-Acting Insulin) Sales Market Share by Application (2016-2021)

Table 48. Europe Basal Insulin (Long-Acting Insulin) Sales by Country (2016-2021) & (K Units)

Table 49. Europe Basal Insulin (Long-Acting Insulin) Sales Market Share by Country (2016-2021)

Table 50. Europe Basal Insulin (Long-Acting Insulin) Revenue by Country (2016-2021) & ($ Millions)

Table 51. Europe Basal Insulin (Long-Acting Insulin) Revenue Market Share by Country (2016-2021)

Table 52. Europe Basal Insulin (Long-Acting Insulin) Sales by Type (2016-2021) & (K Units)

Table 53. Europe Basal Insulin (Long-Acting Insulin) Sales Market Share by Type (2016-2021)

Table 54. Europe Basal Insulin (Long-Acting Insulin) Sales by Application (2016-2021) & (K Units)

Table 55. Europe Basal Insulin (Long-Acting Insulin) Sales Market Share by Application (2016-2021)

Table 56. Middle East & Africa Basal Insulin (Long-Acting Insulin) Sales by Country (2016-2021) & (K Units)

Table 57. Middle East & Africa Basal Insulin (Long-Acting Insulin) Sales Market Share by Country (2016-2021)

Table 58. Middle East & Africa Basal Insulin (Long-Acting Insulin) Revenue by Country (2016-2021) & ($ Millions)

Table 59. Middle East & Africa Basal Insulin (Long-Acting Insulin) Revenue Market Share by Country (2016-2021)

Table 60. Middle East & Africa Basal Insulin (Long-Acting Insulin) Sales by Type (2016-2021) & (K Units)

Table 61. Middle East & Africa Basal Insulin (Long-Acting Insulin) Sales Market Share by Type (2016-2021)

Table 62. Middle East & Africa Basal Insulin (Long-Acting Insulin) Sales by Application (2016-2021) & (K Units)

Table 63. Middle East & Africa Basal Insulin (Long-Acting Insulin) Sales Market Share by Application (2016-2021)

Table 64. Key and Potential Regions of Basal Insulin (Long-Acting Insulin)

Table 65. Key Application and Potential Industries of Basal Insulin (Long-Acting Insulin)

Table 66. Key Challenges of Basal Insulin (Long-Acting Insulin)

Table 67. Key Trends of Basal Insulin (Long-Acting Insulin)

Table 68. Basal Insulin (Long-Acting Insulin) Distributors List

Table 69. Basal Insulin (Long-Acting Insulin) Customer List

Table 70. Global Basal Insulin (Long-Acting Insulin) Sales Forecast by Region (2021-2026) & (K Units)

Table 71. Global Basal Insulin (Long-Acting Insulin) Consumption Market Forecast by Region

Table 72. Global Basal Insulin (Long-Acting Insulin) Revenue Forecast by Region (2021-2026) & ($ millions)

Table 73. Global Basal Insulin (Long-Acting Insulin) Revenue Market Share Forecast by Region (2021-2026)

Table 74. Americas Basal Insulin (Long-Acting Insulin) Sales Forecast by Country (2021-2026) & (K Units)

Table 75. Americas Basal Insulin (Long-Acting Insulin) Revenue Forecast by Country (2021-2026) & ($ millions)

Table 76. APAC Basal Insulin (Long-Acting Insulin) Sales Forecast by Region (2021-2026) & (K Units)

Table 77. APAC Basal Insulin (Long-Acting Insulin) Revenue Forecast by Region (2021-2026) & ($ millions)

Table 78. Europe Basal Insulin (Long-Acting Insulin) Sales Forecast by Country (2021-2026) & (K Units)

Table 79. Europe Basal Insulin (Long-Acting Insulin) Revenue Forecast by Country (2021-2026) & ($ millions)

Table 80. Middle East & Africa Basal Insulin (Long-Acting Insulin) Sales Forecast by Country (2021-2026) & (K Units)

Table 81. Middle East & Africa Basal Insulin (Long-Acting Insulin) Revenue Forecast by Country (2021-2026) & ($ millions)

Table 82. Global Basal Insulin (Long-Acting Insulin) Sales Forecast by Type (2021-2026) & (K Units)

Table 83. Global Basal Insulin (Long-Acting Insulin) Sales Market Share Forecast by Type (2021-2026)

Table 84. Global Basal Insulin (Long-Acting Insulin) Revenue Forecast by Type (2021-2026) & ($ Millions)

Table 85. Global Basal Insulin (Long-Acting Insulin) Revenue Market Share Forecast by Type (2021-2026)

Table 86. Global Basal Insulin (Long-Acting Insulin) Sales Forecast by Application (2021-2026) & (K Units)

Table 87. Global Basal Insulin (Long-Acting Insulin) Sales Market Share Forecast by Application (2021-2026)

Table 88. Global Basal Insulin (Long-Acting Insulin) Revenue Forecast by Application (2021-2026) & ($ Millions)

Table 89. Global Basal Insulin (Long-Acting Insulin) Revenue Market Share Forecast by Application (2021-2026)

Table 90. Novo Nordisk Basic Information, Basal Insulin (Long-Acting Insulin) Manufacturing Base, Sales Area and Its Competitors

Table 91. Novo Nordisk Basal Insulin (Long-Acting Insulin) Product Offered

Table 92. Novo Nordisk Basal Insulin (Long-Acting Insulin) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)

Table 93. Novo Nordisk Main Business

Table 94. Novo Nordisk Latest Developments

Table 95. Sanofi Aventis Basic Information, Basal Insulin (Long-Acting Insulin) Manufacturing Base, Sales Area and Its Competitors

Table 96. Sanofi Aventis Basal Insulin (Long-Acting Insulin) Product Offered

Table 97. Sanofi Aventis Basal Insulin (Long-Acting Insulin) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)

Table 98. Sanofi Aventis Main Business

Table 99. Sanofi Aventis Latest Developments

Table 100. Eli Lilly Basic Information, Basal Insulin (Long-Acting Insulin) Manufacturing Base, Sales Area and Its Competitors

Table 101. Eli Lilly Basal Insulin (Long-Acting Insulin) Product Offered

Table 102. Eli Lilly Basal Insulin (Long-Acting Insulin) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)

Table 103. Eli Lilly Main Business

Table 104. Eli Lilly Latest Developments

Table 105. Biocon Basic Information, Basal Insulin (Long-Acting Insulin) Manufacturing Base, Sales Area and Its Competitors

Table 106. Biocon Basal Insulin (Long-Acting Insulin) Product Offered

Table 107. Biocon Basal Insulin (Long-Acting Insulin) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)

Table 108. Biocon Main Business

Table 109. Biocon Latest Developments

Table 110. Julphar Basic Information, Basal Insulin (Long-Acting Insulin) Manufacturing Base, Sales Area and Its Competitors

Table 111. Julphar Basal Insulin (Long-Acting Insulin) Product Offered

Table 112. Julphar Basal Insulin (Long-Acting Insulin) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)

Table 113. Julphar Main Business

Table 114. Julphar Latest Developments

Table 115. Exir Basic Information, Basal Insulin (Long-Acting Insulin) Manufacturing Base, Sales Area and Its Competitors

Table 116. Exir Basal Insulin (Long-Acting Insulin) Product Offered

Table 117. Exir Basal Insulin (Long-Acting Insulin) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)

Table 118. Exir Main Business

Table 119. Exir Latest Developments

Table 120. Sedico Basic Information, Basal Insulin (Long-Acting Insulin) Manufacturing Base, Sales Area and Its Competitors

Table 121. Sedico Basal Insulin (Long-Acting Insulin) Product Offered

Table 122. Sedico Basal Insulin (Long-Acting Insulin) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)

Table 123. Sedico Main Business

Table 124. Sedico Latest Developments

Table 125. Wockhardt Basic Information, Basal Insulin (Long-Acting Insulin) Manufacturing Base, Sales Area and Its Competitors

Table 126. Wockhardt Basal Insulin (Long-Acting Insulin) Product Offered

Table 127. Wockhardt Basal Insulin (Long-Acting Insulin) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)

Table 128. Wockhardt Main Business

Table 129. Wockhardt Latest Developments

List of Figures

Figure 1. Picture of Basal Insulin (Long-Acting Insulin)

Figure 2. Basal Insulin (Long-Acting Insulin) Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global Basal Insulin (Long-Acting Insulin) Sales Growth Rate 2016-2026 (K Units)

Figure 7. Global Basal Insulin (Long-Acting Insulin) Revenue Growth Rate 2016-2026 ($ Millions)

Figure 8. Basal Insulin (Long-Acting Insulin) Sales by Region (2021 & 2026) & ($ millions)

Figure 9. Product Picture of Lantus

Figure 10. Product Picture of Levemir

Figure 11. Product Picture of Tresiba

Figure 12. Product Picture of Toujeo

Figure 13. Product Picture of Basaglar

Figure 14. Product Picture of Biosimilar Glargines

Figure 15. Global Basal Insulin (Long-Acting Insulin) Sales Market Share by Type in 2020

Figure 16. Global Basal Insulin (Long-Acting Insulin) Revenue Market Share by Type (2016-2021)

Figure 17. Basal Insulin (Long-Acting Insulin) Consumed in Type 1 Diabetes

Figure 18. Global Basal Insulin (Long-Acting Insulin) Market: Type 1 Diabetes (2016-2021) & (K Units)

Figure 19. Basal Insulin (Long-Acting Insulin) Consumed in Type 2 Diabetes

Figure 20. Global Basal Insulin (Long-Acting Insulin) Market: Type 2 Diabetes (2016-2021) & (K Units)

Figure 21. Global Basal Insulin (Long-Acting Insulin) Sales Market Share by Application (2016-2021)

Figure 22. Global Basal Insulin (Long-Acting Insulin) Revenue Market Share by Application in 2020

Figure 23. Basal Insulin (Long-Acting Insulin) Revenue Market by Company in 2020 ($ Million)

Figure 24. Global Basal Insulin (Long-Acting Insulin) Revenue Market Share by Company in 2020

Figure 25. Global Basal Insulin (Long-Acting Insulin) Sales Market Share by Regions (2016-2021)

Figure 26. Global Basal Insulin (Long-Acting Insulin) Revenue Market Share by Region in 2020

Figure 27. Americas Basal Insulin (Long-Acting Insulin) Sales 2016-2021 (K Units)

Figure 28. Americas Basal Insulin (Long-Acting Insulin) Revenue 2016-2021 ($ Millions)

Figure 29. APAC Basal Insulin (Long-Acting Insulin) Sales 2016-2021 (K Units)

Figure 30. APAC Basal Insulin (Long-Acting Insulin) Revenue 2016-2021 ($ Millions)

Figure 31. Europe Basal Insulin (Long-Acting Insulin) Sales 2016-2021 (K Units)

Figure 32. Europe Basal Insulin (Long-Acting Insulin) Revenue 2016-2021 ($ Millions)

Figure 33. Middle East & Africa Basal Insulin (Long-Acting Insulin) Sales 2016-2021 (K Units)

Figure 34. Middle East & Africa Basal Insulin (Long-Acting Insulin) Revenue 2016-2021 ($ Millions)

Figure 35. Americas Basal Insulin (Long-Acting Insulin) Sales Market Share by Country in 2020

Figure 36. Americas Basal Insulin (Long-Acting Insulin) Revenue Market Share by Country in 2020

Figure 37. Americas Basal Insulin (Long-Acting Insulin) Sales Market Share by Type in 2020

Figure 38. Americas Basal Insulin (Long-Acting Insulin) Sales Market Share by Application in 2020

Figure 39. United States Basal Insulin (Long-Acting Insulin) Revenue Growth 2016-2021 ($ Millions)

Figure 40. Canada Basal Insulin (Long-Acting Insulin) Revenue Growth 2016-2021 ($ Millions)

Figure 41. Mexico Basal Insulin (Long-Acting Insulin) Revenue Growth 2016-2021 ($ Millions)

Figure 42. Brazil Basal Insulin (Long-Acting Insulin) Revenue Growth 2016-2021 ($ Millions)

Figure 43. APAC Basal Insulin (Long-Acting Insulin) Sales Market Share by Region in 2020

Figure 44. APAC Basal Insulin (Long-Acting Insulin) Revenue Market Share by Regions in 2020

Figure 45. APAC Basal Insulin (Long-Acting Insulin) Sales Market Share by Type in 2020

Figure 46. APAC Basal Insulin (Long-Acting Insulin) Sales Market Share by Application in 2020

Figure 47. China Basal Insulin (Long-Acting Insulin) Revenue Growth 2016-2021 ($ Millions)

Figure 48. Japan Basal Insulin (Long-Acting Insulin) Revenue Growth 2016-2021 ($ Millions)

Figure 49. Korea Basal Insulin (Long-Acting Insulin) Revenue Growth 2016-2021 ($ Millions)

Figure 50. Southeast Asia Basal Insulin (Long-Acting Insulin) Revenue Growth 2016-2021 ($ Millions)

Figure 51. India Basal Insulin (Long-Acting Insulin) Revenue Growth 2016-2021 ($ Millions)

Figure 52. Australia Basal Insulin (Long-Acting Insulin) Revenue Growth 2016-2021 ($ Millions)

Figure 53. Europe Basal Insulin (Long-Acting Insulin) Sales Market Share by Country in 2020

Figure 54. Europe Basal Insulin (Long-Acting Insulin) Revenue Market Share by Country in 2020

Figure 55. Europe Basal Insulin (Long-Acting Insulin) Sales Market Share by Type in 2020

Figure 56. Europe Basal Insulin (Long-Acting Insulin) Sales Market Share by Application in 2020

Figure 57. Germany Basal Insulin (Long-Acting Insulin) Revenue Growth 2016-2021 ($ Millions)

Figure 58. France Basal Insulin (Long-Acting Insulin) Revenue Growth 2016-2021 ($ Millions)

Figure 59. UK Basal Insulin (Long-Acting Insulin) Revenue Growth 2016-2021 ($ Millions)

Figure 60. Italy Basal Insulin (Long-Acting Insulin) Revenue Growth 2016-2021 ($ Millions)

Figure 61. Russia Basal Insulin (Long-Acting Insulin) Revenue Growth 2016-2021 ($ Millions)

Figure 62. Middle East & Africa Basal Insulin (Long-Acting Insulin) Sales Market Share by Country in 2020

Figure 63. Middle East & Africa Basal Insulin (Long-Acting Insulin) Revenue Market Share by Country in 2020

Figure 64. Middle East & Africa Basal Insulin (Long-Acting Insulin) Sales Market Share by Type in 2020

Figure 65. Middle East & Africa Basal Insulin (Long-Acting Insulin) Sales Market Share by Application in 2020

Figure 66. Egypt Basal Insulin (Long-Acting Insulin) Revenue Growth 2016-2021 ($ Millions)

Figure 67. South Africa Basal Insulin (Long-Acting Insulin) Revenue Growth 2016-2021 ($ Millions)

Figure 68. Israel Basal Insulin (Long-Acting Insulin) Revenue Growth 2016-2021 ($ Millions)

Figure 69. Turkey Basal Insulin (Long-Acting Insulin) Revenue Growth 2016-2021 ($ Millions)

Figure 70. GCC Country Basal Insulin (Long-Acting Insulin) Revenue Growth 2016-2021 ($ Millions)

Figure 71. Channels of Distribution

Figure 72. Distributors Profiles

Please fill the form below, to recieve the report sample


+1